THESEUS PHARMACEUTICALS, INC. Debt Issuance Costs, Noncurrent, Net
THESEUS PHARMACEUTICALS, INC. had Debt Issuance Costs, Noncurrent, Net of $3.80 million as of 2021-12-31, per its 10-K filed 2023-03-09.
Discontinued › Notes
us-gaap:DeferredFinanceCostsNoncurrentNet · last filed 2023-03-09
- 2021-12-31: Debt Issuance Costs, Noncurrent, Net $3.80M.
- 2020-12-31: Debt Issuance Costs, Noncurrent, Net $0.00.
| Period end | Debt Issuance Costs, Noncurrent, Net |
|---|---|
| 2021-12-31 | $3.80M 10-K · filed 2023-03-09 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-10 |